Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-02-14
1993-04-20
Higel, Floyd D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514258, 514260, 514270, 544283, 544284, 544287, C07D23991, A61K 31505
Patent
active
052043541
ABSTRACT:
Substituted quinazolinones of the formula are useful as neurotensin antagonists. ##STR1##
REFERENCES:
patent: 4425269 (1984-01-01), Christy et al.
patent: 4439359 (1984-03-01), Holly et al.
patent: 5064825 (1991-11-01), Chakravarty et al.
patent: 5075313 (1991-12-01), Yu et al.
patent: 5102880 (1992-04-01), Chakravarty et al.
patent: 5128335 (1992-07-01), Guthikonda et al.
patent: 5130306 (1992-07-01), Duggan et al.
G. A. Cain, et al. Neurotensin Based Analgesics: 203rd National Meeting of the Am. Chem. Soc. Apr. 5-10, (1992).
Chakravarty Prasun K.
Naylor E. M.
Ransom Richard W.
Camara Valerie J.
DiPrima Joseph F.
Higel Floyd D.
Merck & Co. , Inc.
Nicholson William H.
LandOfFree
Substituted quinazolinones as neurotensin antagonists useful in does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted quinazolinones as neurotensin antagonists useful in , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted quinazolinones as neurotensin antagonists useful in will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1526348